Context Therapeutics Reports Second Quarter 2025 Operating and Financial Results

Go back to Context Therapeutics Reports Second Quarter 2025 Operating and Financial Results
(NASDAQ: CNTX) Delayed: 0.47 -0.03 (6%)
Previous Close $0.50    52 Week High
Open $0.49    52 Week Low
Day High $0.50    P/E N/A 
Day Low $0.45    EPS
Volume 3,761,465       

(NASDAQ: CNTX) Delayed: 0.47 -0.03 (6%)
Previous Close $0.50    52 Week High
Open $0.49    52 Week Low
Day High $0.50    P/E N/A 
Day Low $0.45    EPS
Volume 3,761,465